Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965 to 1989)

Modifications of technique and impact on ejaculation

J. P. Donohue, J. A. Thornhill, Richard Foster, R. G. Rowland, Richard Bihrle

Research output: Contribution to journalArticle

220 Citations (Scopus)

Abstract

Results with primary retroperitoneal lymphadenectomy in 464 patients with clinical stage A nonseminomatous germ cell testis cancer (1965 to 1989) were reviewed. The false-negative staging error by clinical methods remains at 30%. The relapse rate in pathological stage A cancer patients was 11% (37 of 323), with 2 deaths. For pathological stage B disease 64% of the patients were cured by retroperitoneal lymphadenectomy alone. With modern adjuvant chemotherapy no stage B tumor relapsed since 1979 and the survival rate was 100%. For all 25 years (464 patients) the relapse rate was 14% and the survival rate was 98.9% (3 cancer and 2 noncancer deaths). Because these results are based on preoperative clinical staging, they are directly comparable with series using radiotherapy or surveillance.

Original languageEnglish
Pages (from-to)237-243
Number of pages7
JournalJournal of Urology
Volume149
Issue number2
StatePublished - 1993

Fingerprint

Ejaculation
Testicular Neoplasms
Lymph Node Excision
Survival Rate
Recurrence
Neoplasms
Germ Cell and Embryonal Neoplasms
Adjuvant Chemotherapy
Radiotherapy

Keywords

  • ejaculation
  • lymph node excision
  • retroperitoneal space
  • testicular neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965 to 1989) : Modifications of technique and impact on ejaculation. / Donohue, J. P.; Thornhill, J. A.; Foster, Richard; Rowland, R. G.; Bihrle, Richard.

In: Journal of Urology, Vol. 149, No. 2, 1993, p. 237-243.

Research output: Contribution to journalArticle

@article{ae8a75f4691848a2b6578536f5263c09,
title = "Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965 to 1989): Modifications of technique and impact on ejaculation",
abstract = "Results with primary retroperitoneal lymphadenectomy in 464 patients with clinical stage A nonseminomatous germ cell testis cancer (1965 to 1989) were reviewed. The false-negative staging error by clinical methods remains at 30{\%}. The relapse rate in pathological stage A cancer patients was 11{\%} (37 of 323), with 2 deaths. For pathological stage B disease 64{\%} of the patients were cured by retroperitoneal lymphadenectomy alone. With modern adjuvant chemotherapy no stage B tumor relapsed since 1979 and the survival rate was 100{\%}. For all 25 years (464 patients) the relapse rate was 14{\%} and the survival rate was 98.9{\%} (3 cancer and 2 noncancer deaths). Because these results are based on preoperative clinical staging, they are directly comparable with series using radiotherapy or surveillance.",
keywords = "ejaculation, lymph node excision, retroperitoneal space, testicular neoplasms",
author = "Donohue, {J. P.} and Thornhill, {J. A.} and Richard Foster and Rowland, {R. G.} and Richard Bihrle",
year = "1993",
language = "English",
volume = "149",
pages = "237--243",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965 to 1989)

T2 - Modifications of technique and impact on ejaculation

AU - Donohue, J. P.

AU - Thornhill, J. A.

AU - Foster, Richard

AU - Rowland, R. G.

AU - Bihrle, Richard

PY - 1993

Y1 - 1993

N2 - Results with primary retroperitoneal lymphadenectomy in 464 patients with clinical stage A nonseminomatous germ cell testis cancer (1965 to 1989) were reviewed. The false-negative staging error by clinical methods remains at 30%. The relapse rate in pathological stage A cancer patients was 11% (37 of 323), with 2 deaths. For pathological stage B disease 64% of the patients were cured by retroperitoneal lymphadenectomy alone. With modern adjuvant chemotherapy no stage B tumor relapsed since 1979 and the survival rate was 100%. For all 25 years (464 patients) the relapse rate was 14% and the survival rate was 98.9% (3 cancer and 2 noncancer deaths). Because these results are based on preoperative clinical staging, they are directly comparable with series using radiotherapy or surveillance.

AB - Results with primary retroperitoneal lymphadenectomy in 464 patients with clinical stage A nonseminomatous germ cell testis cancer (1965 to 1989) were reviewed. The false-negative staging error by clinical methods remains at 30%. The relapse rate in pathological stage A cancer patients was 11% (37 of 323), with 2 deaths. For pathological stage B disease 64% of the patients were cured by retroperitoneal lymphadenectomy alone. With modern adjuvant chemotherapy no stage B tumor relapsed since 1979 and the survival rate was 100%. For all 25 years (464 patients) the relapse rate was 14% and the survival rate was 98.9% (3 cancer and 2 noncancer deaths). Because these results are based on preoperative clinical staging, they are directly comparable with series using radiotherapy or surveillance.

KW - ejaculation

KW - lymph node excision

KW - retroperitoneal space

KW - testicular neoplasms

UR - http://www.scopus.com/inward/record.url?scp=0027468610&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027468610&partnerID=8YFLogxK

M3 - Article

VL - 149

SP - 237

EP - 243

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 2

ER -